only 21% of owners of business The USA, and also there is less than a third of respondents in other countries with developed economy carried this factor to number of key incentives. Only 38% of respondents called pressure of the government important incentive that is the lowest indicator among seven factors offered respondents within this International business research. Results of poll of businessmen, directors managing their own business, concerning their last year's activity within corporate responsibility, show that at the head of the list are actions directed on attraction/deduction of employees (see fig. 3). It confirms results of research, testifying that this factor is one of the main incentives of ethic maintaining business.of five most popular initiatives are related to employees and their workers to places - active promotion of the healthy mode work and wellbeing (71%); granting possibilities of training and acquisition of experience (67%); encouragement of a variety is independent from a nationality, a floor and etc./The equal opportunities (64%) and granting the flexible operating schedule (62%). All above-stated measures play an important role in a context of social responsibility, nevertheless, same measures play a key role and in questions of managing personnel.among other measures, increasing the social the companies responsibility, borrows in our research the third place and it is the only thing from five most popular ways, which has no relation to personnel questions. The international practice testifies about existence of essential distinctions in the cultural spheres and questions of the taxation, which have strong impact on indicators certain countries.of control over production wastes and efficiency increase of energy consumption are interconnected. Respondents from many countries including Ireland, Malaysia and Taiwan, reported about taken measures on improvement of control over waste productions and on increase of energy consumption efficiency. In general, leaders among the countries, which are characterized by a maturity economies and shortage of resources, that is strong incentive for initiatives in the field of the effective energy consumption and related areas.of control over waste and questions about energy consumption are more global and universal for observance now, at the growing markets there can be problems, connected with inability to leave on the levels set by more mature economies. Russia is among those countries which started introducing measures of improvement of control over waste and efficiency of energy consumption not so long ago. The company Sanofi Group is one of the few Russian companies which introduced the concept of corporate social responsibility and resolves the issues concerning quality of production, satisfaction of the personnel, ecological safety, etc.
2.2 Sanofi Group company and its CSR program. Results and Perspectives
Sanofi Group is represented in Russia by the following companies: Sanofi, Sanofi Pasteur, Zentiva, Genzyme, Merial. Sanofi products have been available to Russian patients for over 40 years. Currently, Sanofi Russia offers patients a wide range of medicines for socially significant diseases such as diabetes, cancer, cardiovascular disease and thrombosis, as well as diseases of the central nervous system. The world s largest vaccine manufacturer with a portfolio including vaccines against 20 infectious diseases. Sanofi Pasteur has been in the Russian market since +1992 and is now ranked among the leaders of this segment in Russia offering Russian patients 9 different vaccines. Sanofi s generic pharmaceutical platform since +2009, it is the third-largest manufacturer of generic drugs in Europe and one of the fastest growing companies. Its diversified portfolio comprises high-quality, affordable medicines and covers all major areas of medicine. Zentiva has been in the Russian market since 2003.to treat rare diseases in the Sanofi Russia portfolio are represented by products from Genzyme - one of the leading biotech companies in the world which joined the Sanofi group in 2011. Veterinary drugs produced by Merial can also be found in Sanofi Russia s portfolio. Merial, which joined Sanofi in 2011, is a world leader in the field of veterinary medicine that focuses on the development and production of innovative products and solutions to protect the health of animals.is a global integrated healthcare leader and the needs of our patients are at the very core of our work. Our mission is to improve the health of patients, improve the quality of their lives and satisfy their needs. As part of the Company s strategy, Sanofi takes on social, environmental and ethical obligations. Their global strategy focuses on four main categories: «Patient», «Ethics», «People» and «Planet».
Patient1. Fighting diabetes as part of t...
